BKM120 as Second-line Therapy for Advanced Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Advanced Endometrial Cancer
Interventions
DRUG

BKM120

Trial Locations (42)

2610

Novartis Investigative Site, Wilrijk

3000

Novartis Investigative Site, Leuven

3050

Novartis Investigative Site, Parkville

4000

Novartis Investigative Site, Liège

10367

Novartis Investigative Site, Berlin

13353

Novartis Investigative Site, Berlin

20141

Novartis Investigative Site, Milan

28033

Novartis Investigative Site, Madrid

28046

Novartis Investigative Site, Madrid

28207

Carolinas HealthCare Systems Blumenthal Cancer Center, Charlotte

31059

Novartis Investigative Site, Toulouse

33081

Novartis Investigative Site, Aviano

37203

Sarah Cannon Research Institute SCRI (2), Nashville

40138

Novartis Investigative Site, Bologna

46009

Novartis Investigative Site, Valencia

46026

Novartis Investigative Site, Valencia

50937

Novartis Investigative Site, Cologne

55131

Novartis Investigative Site, Mainz

69373

Novartis Investigative Site, Lyon

72015

Novartis Investigative Site, Le Mans

72703

Highlands Oncology Group Dept of Highlands Oncology Grp, Fayetteville

73104

University of Oklahoma Health Sciences Center OU Health, Oklahoma City

76022

Texas Oncology, P.A. Austin, Bedford

78258

South Texas Oncology and Hematology, PA South Tex Onc, San Antonio

80131

Novartis Investigative Site, Napoli

85013

St. Joseph's Hospital & Medical Center St Joseph's, Phoenix

99202

Cancer Care Northwest CC Northwest- Spokane South(3), Spokane

198255

Novartis Investigative Site, Saint Petersburg

229899

Novartis Investigative Site, Singapore

20220410

Novartis Investigative Site, Rio de Janeiro

07962

Morristown Memorial Hospital MMH, Morristown

V5Z 4E6

Novartis Investigative Site, Vancouver

L8V 5C2

Novartis Investigative Site, Hamilton

M5G 2M9

Novartis Investigative Site, Toronto

H2L 4M1

Novartis Investigative Site, Montreal

06189

Novartis Investigative Site, Nice

00168

Novartis Investigative Site, Roma

464-8681

Novartis Investigative Site, Nagoya

104-0045

Novartis Investigative Site, Chuo-ku

105-8471

Novartis Investigative Site, Minato-ku

00973

Novartis Investigative Site, Warsaw

08036

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY